207 related articles for article (PubMed ID: 37307224)
21. The influence of gut microbiota on drug metabolism and toxicity.
Li H; He J; Jia W
Expert Opin Drug Metab Toxicol; 2016; 12(1):31-40. PubMed ID: 26569070
[TBL] [Abstract][Full Text] [Related]
22. Connecting the dots: Targeting the microbiome in drug toxicity.
Luo Y; Zhou T
Med Res Rev; 2022 Jan; 42(1):83-111. PubMed ID: 33856076
[TBL] [Abstract][Full Text] [Related]
23. Application of freeze-drying in the development of oral drug delivery systems.
Siow CR; Wan Sia Heng P; Chan LW
Expert Opin Drug Deliv; 2016 Nov; 13(11):1595-1608. PubMed ID: 27267745
[TBL] [Abstract][Full Text] [Related]
24. Potential Implications of Gut Microbiota in Drug Pharmacokinetics and Bioavailability.
Flowers SA; Bhat S; Lee JC
Pharmacotherapy; 2020 Jul; 40(7):704-712. PubMed ID: 32463481
[TBL] [Abstract][Full Text] [Related]
25. Adverse effects of pharmaceutical excipients in drug therapy.
Wong YL
Ann Acad Med Singap; 1993 Jan; 22(1):99-102. PubMed ID: 8503648
[TBL] [Abstract][Full Text] [Related]
26. Pharmacomicrobiomics and type 2 diabetes mellitus: A novel perspective towards possible treatment.
Jia L; Huang S; Sun B; Shang Y; Zhu C
Front Endocrinol (Lausanne); 2023; 14():1149256. PubMed ID: 37033254
[TBL] [Abstract][Full Text] [Related]
27. Biologic excipients: Importance of clinical awareness of inactive ingredients.
Ionova Y; Wilson L
PLoS One; 2020; 15(6):e0235076. PubMed ID: 32584876
[TBL] [Abstract][Full Text] [Related]
28. Excipient variability and its impact on dosage form functionality.
Dave VS; Saoji SD; Raut NA; Haware RV
J Pharm Sci; 2015 Mar; 104(3):906-15. PubMed ID: 25561249
[TBL] [Abstract][Full Text] [Related]
29. Recent trends in stabilising peptides and proteins in pharmaceutical formulation - considerations in the choice of excipients.
Jorgensen L; Hostrup S; Moeller EH; Grohganz H
Expert Opin Drug Deliv; 2009 Nov; 6(11):1219-30. PubMed ID: 19678792
[TBL] [Abstract][Full Text] [Related]
30. Excipients in parenteral formulations: selection considerations and effective utilization with small molecules and biologics.
Rayaprolu BM; Strawser JJ; Anyarambhatla G
Drug Dev Ind Pharm; 2018 Oct; 44(10):1565-1571. PubMed ID: 29863908
[TBL] [Abstract][Full Text] [Related]
31. Delayed Hypersensitivity Reactions Caused by Drug Excipients: A Literature Review.
Caballero ML; Quirce S
J Investig Allergol Clin Immunol; 2020; 30(6):400-408. PubMed ID: 32376520
[TBL] [Abstract][Full Text] [Related]
32. Effect and Mechanism of Pharmaceutical Excipients on Berberine to Alleviate Ulcerative Colitis via Regulating Gut Microbiota.
Wu C; Zheng T; Chen H; Zou P; Zhang M; Wang J; Li N; Zhang Y; Li Y; Dong Z
Molecules; 2022 Sep; 27(18):. PubMed ID: 36144733
[TBL] [Abstract][Full Text] [Related]
33. The Impact of Food Additives on the Abundance and Composition of Gut Microbiota.
Zhou X; Qiao K; Wu H; Zhang Y
Molecules; 2023 Jan; 28(2):. PubMed ID: 36677689
[TBL] [Abstract][Full Text] [Related]
34. Active Machine learning for formulation of precision probiotics.
McCoubrey LE; Seegobin N; Elbadawi M; Hu Y; Orlu M; Gaisford S; Basit AW
Int J Pharm; 2022 Mar; 616():121568. PubMed ID: 35150845
[TBL] [Abstract][Full Text] [Related]
35. Pharmaceutical excipients - quality, regulatory and biopharmaceutical considerations.
Elder DP; Kuentz M; Holm R
Eur J Pharm Sci; 2016 May; 87():88-99. PubMed ID: 26699228
[TBL] [Abstract][Full Text] [Related]
36. Applications of various analytical techniques in quality control of pharmaceutical excipients.
Kumar M; Bhatia R; Rawal RK
J Pharm Biomed Anal; 2018 Aug; 157():122-136. PubMed ID: 29787965
[TBL] [Abstract][Full Text] [Related]
37. In vitro evaluation of extemporaneously compounded immediate-release capsules with premixed excipients, based on the biopharmaceutics classification system (BCS) of the drugs.
Pinheiro VA; Danopoulos P; Demirdjian L; Nogueira RJ; Dubois F
Int J Pharm Compd; 2013; 17(5):424-31. PubMed ID: 24459788
[TBL] [Abstract][Full Text] [Related]
38. Compressed orally disintegrating tablets: excipients evolution and formulation strategies.
Al-khattawi A; Mohammed AR
Expert Opin Drug Deliv; 2013 May; 10(5):651-63. PubMed ID: 23387409
[TBL] [Abstract][Full Text] [Related]
39. Exposure to anti-seizure medications impact growth of gut bacterial species and subsequent host response.
Ilhan ZE; Brochard V; Lapaque N; Auvin S; Lepage P
Neurobiol Dis; 2022 Jun; 167():105664. PubMed ID: 35183703
[TBL] [Abstract][Full Text] [Related]
40. A Nitrite Excipient Database: A Useful Tool to Support N-Nitrosamine Risk Assessments for Drug Products.
Boetzel R; Schlingemann J; Hickert S; Korn C; Kocks G; Luck B; Blom G; Harrison M; François M; Allain L; Wu Y; Bousraf Y
J Pharm Sci; 2023 Jun; 112(6):1615-1624. PubMed ID: 35500671
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
